Browsing by Keyword : Antineoplastic Agents/adverse effects

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 9 of 9

Pub YearTitleAuthor(s)
2017Adjuvant concurrent chemoradiotherapy with low-dose daily cisplatin for extrahepatic bile duct cancer강석윤, 김지훈, 노오규, 박래웅, 오영택, 윤덕용, 이현우, 전미선
2017Altered intrinsic brain activity after chemotherapy in patients with gastric cancer: A preliminary study김현지
2009Cathepsin D and eukaryotic translation elongation factor 1 as promising markers of cellular senescence.윤계순
2008Change of platelet activation markers using flow cytometry in patients with hematology/oncology disorders after transfusion.박준성, 이위교, 임영애, 조성란
2009Chemotherapy-related amenorrhea in premenopausal women with breast cancer.-
2015Clinical predictors associated with proton pump inhibitor-induced hypomagnesemia.강대용
2017Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results강석윤
2016Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study박준성
2014Novel synthetic protective compound, KR-22335, against cisplatin-induced auditory cell death.강성운, 김철호, 신유섭
1

Browse